Indaptus Therapeutics, Inc. (INDP) Balance Sheet
INDP balance sheet, 2025
December 31, 2025 · U.S. dollars$9.3M assets = $6.2M liabilities + $3.2M equity
Both columns are drawn to the same scale: what INDP owns equals what it owes plus shareholders’ equity. Hover a block for its value.
INDP financial health
Current ratio1.51
Comfortable · current assets cover current liabilities 1.51×
Equity / assets33.9%
Balanced · of assets funded by shareholders
Goodwill & intangibles0.0%
Mostly tangible · of total assets
Descriptive bands, not a rating. Fiscal 2025.
INDP balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $24.7M2016 | $9.3M2025 | −10.3%/yr | |
| Total liabilities | $2.0M2016 | $6.2M2025 | +13.2%/yr | |
| Shareholders’ equity | $22.7M2016 | $3.2M2025 | −19.7%/yr | |
| Cash & short-term investments | $18.3M2016 | $8.5M2025 | −8.2%/yr | |
| Total debt | $1.3M2019 | $84,1642024 | −42.5%/yr | |
| Net cash (debt) | $8.7M2019 | $5.7M2024 | −$3.0M | |
| Working capital | $18.8M2016 | $3.2M2025 | −$15.6M | |
| Current ratio | 10.772016 | 1.512025 | −9.26 | |
| Debt / equity | 0.122019 | 0.022024 | −0.10 |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
INDP assets
Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current
INDP liabilities and equity
Current liabilitiesLong-term debtOther long-term liabilitiesEquity
INDP debt vs cash
Total debtCash & ST investmentsNet cash (debt)
Debt includes short- and long-term borrowings and, where reported, lease obligations.
INDP balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $8.5M | $5.8M | $13.4M | $26.4M | $39.1M | $1.6M | $10.1M | $40.6M | $55.2M | $18.3M |
| Cash & equivalents | $8.5M | $5.8M | $13.4M | $9.6M | $39.1M | $1.6M | $9.3M | $39.2M | $53.4M | $16.4M |
| Short-term investments | — | — | $0 | $16.8M | $0 | — | $770,000 | $1.3M | $1.8M | $1.9M |
| Receivables | $0 | $0 | $0 | $0 | $21,056 | $0 | $3.5M | $2.0M | $478,000 | $721,000 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $802,540 | $831,577 | $633,156 | $811,433 | $1.2M | $94,500 | $197,000 | $955,000 | $647,000 | $1.7M |
| Total current assets | $9.3M | $6.6M | $14.0M | $27.2M | $40.4M | $1.7M | $13.7M | $43.6M | $56.3M | $20.7M |
| Property, plant & equipment (net) | $0 | $82,175 | $173,941 | $81,313 | $172,888 | $1,349 | $3.8M | $12.2M | $8.2M | $4.0M |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $638,251 | $754,728 | $738,251 | $16,477 | $44,445 | $3.7M | $5.7M | $0 | $0 |
| Total assets | $9.3M | $7.3M | $14.9M | $28.1M | $40.6M | $1.8M | $21.3M | $61.5M | $64.5M | $24.7M |
| Liabilities | ||||||||||
| Accounts payable | $544,057 | $870,229 | $806,004 | $1.4M | $2.6M | $155,957 | $3.5M | $2.8M | $1.9M | $1.2M |
| Short-term debt | — | $84,164 | $101,705 | $80,494 | $96,465 | $96,465 | $544,000 | — | — | — |
| Total current liabilities | $6.2M | $3.4M | $2.8M | $3.4M | $4.6M | $2.0M | $8.3M | $7.7M | $5.7M | $1.9M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | $0 | $84,164 | $175,053 | $80,494 | $169,327 | $0 | — | — | — | — |
| Other long-term liabilities | $0 | $0 | $73,348 | $1.5M | $72,862 | $72,862 | $1.4M | $309,000 | $0 | $96,999 |
| Total liabilities | $6.2M | $3.4M | $2.8M | $3.4M | $4.7M | $2.0M | $9.7M | $8.0M | $5.7M | $2.0M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $21,674 | $120,139 | $84,011 | $84,011 | $82,586 | $19,447 | $727,000 | $727,000 | $727,000 | $727,000 |
| Retained earnings (deficit) | −$81.3M | −$60.4M | −$45.4M | −$30.0M | −$15.7M | −$8.0M | −$189.4M | −$141.8M | −$98.3M | −$62.6M |
| Accumulated other comprehensive income | — | — | $0 | $96,434 | — | — | −$727,000 | — | −$378,000 | −$378,000 |
| Total shareholders' equity | $3.2M | $3.9M | $12.1M | $24.6M | $35.9M | −$237,701 | $11.5M | $53.5M | $58.8M | $22.7M |
| Key figures | ||||||||||
| Total debt | — | $84,164 | $175,053 | $80,494 | $169,327 | $169,327 | $1.3M | — | — | — |
| Net cash (debt) | — | $5.7M | $13.2M | $26.4M | $39.0M | $1.5M | $8.7M | — | — | — |
| Working capital | $3.2M | $3.2M | $11.2M | $23.8M | $35.8M | −$283,495 | $5.4M | $35.9M | $50.6M | $18.8M |
| Tangible book value | $3.2M | $3.9M | $12.1M | $24.6M | $35.9M | −$237,701 | $11.5M | $53.5M | $58.8M | $22.7M |
| Current ratio | 1.51 | 1.95 | 5.05 | 7.94 | 8.77 | 0.86 | 1.65 | 5.69 | 9.80 | 10.77 |
| Quick ratio | 1.38 | 1.71 | 4.82 | 7.70 | 8.50 | 0.81 | 1.62 | 5.57 | 9.69 | 9.90 |
| Debt / equity | — | 0.02 | 0.01 | 0.00 | 0.00 | — | 0.12 | — | — | — |
| Equity / assets | 33.9% | 53.8% | 80.9% | 87.8% | 88.5% | −13.4% | 54.2% | 87.1% | 91.1% | 91.8% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $11.6M | $1.5M | $8.5M | $5.8M | $6.2M | $3.9M | $5.8M | $7.4M | $7.3M | $9.7M | $13.4M | $16.0M |
| Cash & equivalents | $7.6M | $1.5M | $8.5M | $5.8M | $6.2M | $3.9M | $5.8M | $7.4M | $7.3M | $9.7M | $13.4M | $16.0M |
| Short-term investments | $4.0M | — | — | — | — | — | — | — | — | — | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $434,136 | $683,221 | $802,540 | $613,354 | $255,357 | $1.1M | $831,577 | $248,737 | $186,726 | $551,031 | $633,156 | $879,524 |
| Total current assets | $12.0M | $2.2M | $9.3M | $6.4M | $6.4M | $5.0M | $6.6M | $7.6M | $7.5M | $10.3M | $14.0M | $16.8M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $8,487 | $33,577 | $58,119 | $82,175 | $105,655 | $128,630 | $151,118 | $173,941 | $195,806 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $0 | $0 | $0 | $392,572 | $392,572 | $392,572 | $638,251 | $504,728 | $504,728 | $504,728 | $754,728 | $754,728 |
| Total assets | $12.0M | $2.2M | $9.3M | $6.8M | $6.8M | $5.4M | $7.3M | $8.2M | $8.1M | $10.9M | $14.9M | $17.8M |
| Liabilities | ||||||||||||
| Accounts payable | $615,426 | $557,367 | $544,057 | $707,420 | $618,515 | $1.3M | $870,229 | $555,949 | $416,555 | $405,457 | $806,004 | $617,270 |
| Short-term debt | — | — | — | $8,686 | $6.5M | $59,512 | $84,164 | $103,982 | $103,223 | $102,464 | $101,705 | $101,004 |
| Deferred revenue | — | — | — | — | — | — | — | — | — | — | — | −$617,270 |
| Total current liabilities | $615,426 | $932,999 | $6.2M | $2.2M | $8.5M | $2.6M | $3.4M | $2.2M | $1.9M | $1.5M | $2.8M | $2.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Lease obligations | — | — | $0 | $8,686 | $34,373 | $59,512 | $84,164 | $107,989 | $130,802 | $153,128 | $175,053 | $196,241 |
| Other long-term liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $4,007 | $27,579 | $50,664 | $73,348 | $95,237 |
| Total liabilities | $615,426 | $932,999 | $6.2M | $2.2M | $8.5M | $2.6M | $3.4M | $2.2M | $2.0M | $1.6M | $2.8M | $2.5M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $1.3M | $1.1M | $21,674 | $16,420 | $6,050 | $160,344 | $120,139 | $101,969 | $85,531 | $85,389 | $84,011 | $84,011 |
| Retained earnings (deficit) | −$85.6M | −$83.8M | −$81.3M | −$73.2M | −$70.2M | −$65.0M | −$60.4M | −$56.3M | −$53.2M | −$49.2M | −$45.4M | −$41.4M |
| Accumulated other comprehensive income | — | — | — | — | — | — | — | $0 | — | — | $0 | $0 |
| Total shareholders' equity | $11.4M | $1.2M | $3.2M | $4.6M | −$1.7M | $2.8M | $3.9M | $6.0M | $6.2M | $9.4M | $12.1M | $15.3M |
| Key figures | ||||||||||||
| Total debt | — | — | — | $8,686 | $6.5M | $59,512 | $84,164 | $107,989 | $130,802 | $153,128 | $175,053 | $196,241 |
| Net cash (debt) | — | — | — | $5.8M | −$379,175 | $3.8M | $5.7M | $7.3M | $7.2M | $9.6M | $13.2M | $15.8M |
| Working capital | $11.4M | $1.2M | $3.2M | $4.2M | −$2.1M | $2.3M | $3.2M | $5.4M | $5.6M | $8.8M | $11.2M | $14.5M |
| Tangible book value | $11.4M | $1.2M | $3.2M | $4.6M | −$1.7M | $2.8M | $3.9M | $6.0M | $6.2M | $9.4M | $12.1M | $15.3M |
| Book value per share | $0.10 | — | — | — | — | — | — | — | — | — | — | — |
| Shares outstanding | 116.1M | — | — | — | — | — | — | — | — | — | — | — |
| Current ratio | 19.48 | 2.34 | 1.51 | 2.88 | 0.75 | 1.90 | 1.95 | 3.42 | 3.88 | 6.70 | 5.05 | 7.12 |
| Quick ratio | 18.77 | 1.61 | 1.38 | 2.61 | 0.72 | 1.49 | 1.71 | 3.31 | 3.79 | 6.34 | 4.82 | 6.75 |
| Debt / equity | — | — | — | 0.00 | — | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 |
| Equity / assets | 94.9% | 57.2% | 33.9% | 67.3% | −24.5% | 51.7% | 53.8% | 72.9% | 75.9% | 85.5% | 80.9% | 86.2% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 17, 2026); data from EODHD.
INDP financial position
At the end of fiscal 2025 (December 31, 2025), Indaptus Therapeutics had total assets of $9.3 million (up 26.9% from a year earlier), total liabilities of $6.2 million and shareholders' equity of $3.2 million. Its current ratio was 1.51. In the latest quarter (ended June 30, 2026) total assets were $12.0 million and equity $11.4 million.
Related: INDP income statement, INDP cash flow statement, INDP key metrics. See the INDP stock overview for the latest quote and news.
INDP balance sheet FAQ
What are Indaptus Therapeutics's total assets?
Indaptus Therapeutics reported total assets of $9.3 million at the end of fiscal 2025 (December 31, 2025), compared with $7.3 million a year earlier.
How much cash does Indaptus Therapeutics have?
Indaptus Therapeutics held $8.5 million in cash and short-term investments at the end of fiscal 2025.
What is Indaptus Therapeutics's book value?
Indaptus Therapeutics's shareholders' equity (book value) was $3.2 million at the end of fiscal 2025.
What is Indaptus Therapeutics's current ratio?
Indaptus Therapeutics had current assets of $9.3 million and current liabilities of $6.2 million, a current ratio of 1.51 (it can cover its short-term obligations).